In 2010, a genome-wide association study (GWAS) identified genetic variants at the transmembrane protein 106 B (TMEM106B) gene locus as the first genetic modifiers of FTLD-TDP [59]. The gene discussed is TMEM106B; the disease is torsades de pointes.